⌘K

Login Start Free

Home/Filings/4/0002009236-25-000008

4//SEC Filing

Pitofsky Jason 4

Accession 0002009236-25-000008

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 5:38 PM ET

Size

9.7 KB

Accession

0002009236-25-000008

Insider Transaction Report

Form 4

Period: 2025-12-05

REGENERON PHARMACEUTICALS, INC.REGN

VP Controller

Transactions

Award
Common Stock
2025-12-05+2,064→ 6,297 total
Tax Payment
Common Stock
2025-12-08$712.94/sh−989$705,098→ 5,308 total
Award
Non-Qualified Stock Option (right to buy)
2025-12-05+2,261→ 2,261 total
Exercise: $726.71Exp: 2035-12-05→ Common Stock (2,261 underlying)

Holdings

Common Stock
(indirect: By 401(k))
31
Common Stock
(indirect: By Spouse)
179

Footnotes (2)

[F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.
[F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1

filerCIK 0002009236

Filing Metadata

Form type: 4
Filed: Dec 8, 7:00 PM ET
Accepted: Dec 9, 5:38 PM ET
Size: 9.7 KB

View on SEC.gov